4//SEC Filing
REPLIGEN CORP 4
Accession 0001140361-14-010475
$RGENCIK 0000730272operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 1:03 PM ET
Size
7.4 KB
Accession
0001140361-14-010475
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
RUSCHE JAMES R
Senior Vice President
Transactions
- Award
Stock Option (Right to Buy)
2014-02-27+12,727→ 12,727 totalExercise: $15.91Exp: 2024-02-27→ Common Stock (12,727 underlying) - Award
Common Stock
2014-02-27+6,644→ 143,914 total
Footnotes (2)
- [F1]Mr. Rusche was awarded 6,644 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. 2,214 Restricted Stock Units vest on 2/27/2015. 2,215 Restricted Stock Units vest on each of 2/27/2016 and 2/27/2017. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]4,242 shares vest and become exercisable on each of 2/27/2015 and 2/27/2016. 4,243 shares vest and become exercisable on 2/27/2017.
Documents
Issuer
REPLIGEN CORP
CIK 0000730272
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000730272
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 1:03 PM ET
- Size
- 7.4 KB